Onyvax-P
an allogeneic whole-cell vaccine, for the potential treatment of prostate cancer; in phase II clinical trials (Oct 2005)
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
Related Drugs and Biologics